145 related articles for article (PubMed ID: 32429447)
21. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.
Liang B; Zhao J; Wang X
Genes Cancer; 2017 May; 8(5-6):600-607. PubMed ID: 28740578
[TBL] [Abstract][Full Text] [Related]
23. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
[TBL] [Abstract][Full Text] [Related]
24. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
Paulino AC; Mayr NA; Simon JH; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
Poremba C; Scheel C; Hero B; Christiansen H; Schaefer KL; Nakayama Ji; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
J Clin Oncol; 2000 Jul; 18(13):2582-92. PubMed ID: 10893290
[TBL] [Abstract][Full Text] [Related]
26. Long-term hepatic outcomes in survivors of stage 4S and 4 neuroblastoma in infancy.
French AE; Irwin MS; Navarro OM; Greenberg M; Nathan PC
Pediatr Blood Cancer; 2012 Feb; 58(2):283-8. PubMed ID: 21370436
[TBL] [Abstract][Full Text] [Related]
27. Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.
Parisi T; Yuan TL; Faust AM; Caron AM; Bronson R; Lees JA
Mol Cell Biol; 2007 Mar; 27(6):2283-93. PubMed ID: 17210634
[TBL] [Abstract][Full Text] [Related]
28. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.
Ziebold U; Reza T; Caron A; Lees JA
Genes Dev; 2001 Feb; 15(4):386-91. PubMed ID: 11230146
[TBL] [Abstract][Full Text] [Related]
29. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
[TBL] [Abstract][Full Text] [Related]
30. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
31. Liver transplantation as a potentially lifesaving measure in neuroblastoma stage 4S.
Holsten T; Schuster T; Grabhorn E; Hero B; Frühwald MC
Pediatr Hematol Oncol; 2017 Feb; 34(1):17-23. PubMed ID: 28085536
[TBL] [Abstract][Full Text] [Related]
32. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma: A Case of Massive Hepatomegaly.
Ali Q; Bilal MI; Ansari FA; Gondal MUR; Arif A
Cureus; 2021 Jul; 13(7):e16731. PubMed ID: 34513362
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
Meng X; Li H; Fang E; Feng J; Zhao X
Front Oncol; 2020; 10():1411. PubMed ID: 32974147
[No Abstract] [Full Text] [Related]
35. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
[TBL] [Abstract][Full Text] [Related]
36. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific targeting of cell fate regulatory genes by E2f factors.
Julian LM; Liu Y; Pakenham CA; Dugal-Tessier D; Ruzhynsky V; Bae S; Tsai SY; Leone G; Slack RS; Blais A
Cell Death Differ; 2016 Apr; 23(4):565-75. PubMed ID: 25909886
[TBL] [Abstract][Full Text] [Related]
38. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
39. Retinoblastoma protein represses E2F3 to maintain Sertoli cell quiescence in mouse testis.
Rotgers E; Cisneros-Montalvo S; Nurmio M; Toppari J
J Cell Sci; 2019 Jul; 132(14):. PubMed ID: 31308245
[TBL] [Abstract][Full Text] [Related]
40. Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma.
Markaki EA; Tsopanomichalou M; Dimitriou H; Stiakaki E; Perdikoyanni C; Spandidos D; Kalmanti M
Pediatr Hematol Oncol; 2001 Mar; 18(2):101-10. PubMed ID: 11255727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
